Oral Session 2-14C Post-transplant: Prognosis

[OS2-14C-4] Evaluation of TIM-3+ AML stem cells should be significant to predict early relapses after allo-SCT

Takuya Harada^1,2, Teppei Sakoda^1,2, Yoshikane Kikushige², Hidetoshi Irifune^1,2, Goichi Yoshimoto^2,3, Toshihiro Miyamoto^2,3, Koichi Akashi^1,2,3 (1.Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan, 2.Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 3.Department of Hematology/Oncology, Kyushu University Hospital, Fukuoka, Japan)